Two Labs is an industry leader in all facets of pharma services. Our professional, experienced team offers a wealth of skills and knowledge to manage the complexities of pharma product commercialization, market access and market intelligence.
As the cell and gene therapy market has exponentially grown in recent years — with some reports predicting it will reach $24.4 billion with 54 to 74 approvals by 2030 — many manufacturers are learning the hard way just how complex it can be to launch these products.
It’s no surprise that putting together a successful launch strategy for an oncology product is a complex process. And we’ve heard from many of our emerging pharma clients that it’s intimidating to see how saturated and competitive the landscape is.
In a market where most medical affairs and medical communications service providers are built to support large pharma, Two Labs is aiming to fill the gap for small and emerging biopharma and biotech manufacturers with the launch of Medical Affairs & Communications.
The main question that sits at the center of the most common licensing questions and obstacles for cell and gene strategies: how do companies license a product that is often never touched by the parties that need to hold the license?
The partnership expands Two Labs’ suite of services and broadens its integration competency to include government price reporting
Oncology and other specialty therapies continue to get more and more expensive for payers, placing immense financial pressure on the HCP. The percentage increase in worldwide spending on oncology medications went up by double digits every year between 2013 and 2018, and reached nearly $150 billion in 2018. Modern cancer therapies significantly improve disease outlook, but with a tremendous cost of treatment.
Through every step of the commercial journey, Two Labs is your partner in driving success.
110 Riverbend Avenue, Suite 100
Powell, OH 43065
Phone: (614) 389-4004
Fax: (866) 259-4324
Email: info@twolabs.com
© Copyright 2023 | Powered by PRISM